Evidence map›Paper›PMID 28606795›Full record

ArticleThe American journal of pathology2017

Endothelium-Independent Primitive Myxoid Vascularization Creates Invertebrate-Like Channels to Maintain Blood Supply in Optic Gliomas.

Matija Snuderl, Guoan Zhang, Pamela Wu, Tara S Jennings, Seema Shroff, Valerio Ortenzi, Rajan Jain, Benjamin Cohen, Jason J Reidy, Mitchell S Dushay and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Matija SnuderlDivision of Neuropathology, Department of Pathology, New York University Langone Medical Center and Medical School, New York, New York; Department of Neurology, New York University Langone Medical Center and Medical School, New York, New York.
Guoan ZhangDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, New York; Kimmel Center for Biology and Medicine at the Skirball Institute, New York University School of Medicine, New York, New York.
Pamela WuDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, New York; Institute of Systems Genetics, New York University Langone Medical Center, New York, New York.
Tara S JenningsDivision of Neuropathology, Department of Pathology, New York University Langone Medical Center and Medical School, New York, New York.
Seema ShroffDivision of Neuropathology, Department of Pathology, New York University Langone Medical Center and Medical School, New York, New York.
Valerio OrtenziDivision of Neuropathology, Department of Pathology, New York University Langone Medical Center and Medical School, New York, New York.
Rajan JainDepartment of Radiology, New York University Langone Medical Center and Medical School, New York, New York; Department of Neurosurgery, New York University Langone Medical Center and Medical School, New York, New York.
Benjamin CohenDepartment of Radiology, New York University Langone Medical Center and Medical School, New York, New York.
Jason J ReidyDepartment of Pathology, Mount Sinai Beth Israel Medical Center, New York, New York.
Mitchell S DushayDepartment of Entomology, Cornell University, Ithaca, New York.
Jeffrey H WisoffDepartment of Neurosurgery, New York University Langone Medical Center and Medical School, New York, New York; Division of Pediatric Neurosurgery, New York University Langone Medical Center and Medical School, New York, New York.
David H HarterDepartment of Neurosurgery, New York University Langone Medical Center and Medical School, New York, New York; Division of Pediatric Neurosurgery, New York University Langone Medical Center and Medical School, New York, New York.
Matthias A KarajannisDivision of Pediatric Hematology/Oncology, Department of Pediatrics and Otolaryngology, New York University Langone Medical Center and Perlmutter Cancer Center, New York, New York.
David FenyoDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, New York; Institute of Systems Genetics, New York University Langone Medical Center, New York, New York.
Thomas A NeubertDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, New York; Kimmel Center for Biology and Medicine at the Skirball Institute, New York University School of Medicine, New York, New York.
David ZagzagDivision of Neuropathology, Department of Pathology, New York University Langone Medical Center and Medical School, New York, New York; Department of Neurosurgery, New York University Langone Medical Center and Medical School, New York, New York; Microvascular and Molecular Neurooncology Laboratory, Department of Pathology, New York University Langone Medical Center, New York, New York. Electronic address: dz4@nyu.edu.
NYU Langone Health · USNew York University · USCornell University · USMount Sinai Beth Israel · US

Funding

Project-005UL1TR001445 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BREDELLA, MIRIAM ANTOINETTE, HOCHMAN, JUDITH S · 2015 to 2025
$103.5M
Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
Protein Mass Spectrometry Core Facility for NeuroscienceP30NS050276 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI NEUBERT, THOMAS A · 2005 to 2015
$7.9M
LTQ-Orbitrap Mass Spectrometer.S10RR027990 · NCRR · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI NEUBERT, THOMAS A · 2011 to 2011
$600k
Novel CXCR4 Therapeutics to Block Bevacizumab-Induced Glioma Dissemination.R21NS074055 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ZAGZAG, DAVID · 2011 to 2013
$570k
NCATS NIH HHS UL1 TR001445NCI NIH HHS P30 CA016087NCRR NIH HHS S10 RR027990NINDS NIH HHS P30 NS050276NINDS NIH HHS R21 NS074055
6 · The paper itself

Abstract

Optic gliomas are brain tumors characterized by slow growth, progressive loss of vision, and limited therapeutic options. Optic gliomas contain various amounts of myxoid matrix, which can represent most of the tumor mass. We sought to investigate biological function and protein structure of the myxoid matrix in optic gliomas to identify novel therapeutic targets. We reviewed histological features and clinical imaging properties, analyzed vasculature by immunohistochemistry and electron microscopy, and performed liquid chromatography-mass spectrometry on optic gliomas, which varied in the amount of myxoid matrix. We found that although subtypes of optic gliomas are indistinguishable on imaging, the microvascular network of pilomyxoid astrocytoma, a subtype of optic glioma with abundant myxoid matrix, is characterized by the presence of endothelium-free channels in the myxoid matrix. These tumors show normal perfusion by clinical imaging and lack histological evidence of hemorrhage organization or thrombosis. The myxoid matrix is composed predominantly of the proteoglycan versican and its linking protein, a vertebrate hyaluronan and proteoglycan link protein 1. We propose that pediatric optic gliomas can maintain blood supply without endothelial cells by using invertebrate-like channels, which we termed primitive myxoid vascularization. Enzymatic targeting of the proteoglycan versican/hyaluronan and proteoglycan link protein 1 rich myxoid matrix, which is in direct contact with circulating blood, can provide novel therapeutic avenues for optic gliomas of childhood.

Indexed as

Blood VesselsEndothelial CellsEndotheliumHumansNeovascularization, PathologicOptic Nerve GliomaRetrospective Studies

Identifiers

PMID28606795
PMCPMC5530906
OpenAlexW2622527137

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.